Polyphor is a clinical stage biopharmaceutical company focused on the discovery and development of immuno-oncology compounds and a new class of antibiotics against Gram-negative bacteria, the Outer Membrane Protein Targeting Antibiotics (OMPTA).

Location
Facts & figures
  • Type of organization
    Public company
  • Year of foundation
    1996
  • Number of employees in Switzerland
    50-149
Key business